Objective: Despite the clear benefits of physical activity and related behaviors on prognosis, most patients experiencing an acute coronary syndrome (ACS) remain nonadherent to these behaviors. Deficits in positive psychological constructs (e.g., optimism) are linked to reduced participation in health behaviors, supporting the potential utility of a positive psychology (PP)-based intervention in post-ACS patients. Accordingly, we aimed to identify optimal components of a PP-based intervention to promote post-ACS physical activity. Methods: As part of a multiphase optimization strategy, we completed a randomized factorial trial with eight conditions in 128 post-ACS patients to efficiently identify best-performing intervention components. All participants received a PP-based intervention, with conditions varying in duration (presence/absence of booster sessions), intensity (weekly/daily PP exercises), and content (PP alone or combined with motivational interviewing), allowing three concurrent comparisons within the trial. The study aims included assessments of the overall feasibility, acceptability, and impact of the intervention, along with the primary aim of determining which components were associated with objectively measured physical activity and self-reported health behavior adherence at 16 weeks, assessed using longitudinal models. Results: The intervention was well accepted and associated with substantial improvements in behavioral and psychological outcomes. Booster sessions were associated with greater activity to a nearly significant degree (β = 8.58, 95% confidence interval = −0.49-17.65, effect size difference = .43, p = .064), motivational interviewing was associated with overall adherence (β = 0.95, 95% confidence interval = 0.02-1.87, effect size difference = .39, p = .044), and weekly exercise completion was generally superior to daily. Conclusions: These findings will enable optimization of the PP-based intervention in preparation for a well-powered controlled trial. Clinical Trial Registration: Clinicaltrials.gov, NCT02754895.
INTRODUCTION
A cute coronary syndrome (ACS; myocardial infarction or unstable angina) is an acute and life-threatening manifestation of heart disease experienced by more than 7 million persons worldwide each year (1) . Adherence to key cardiac health behaviors is critical for post-ACS recovery, because patients who fail to adhere to these health behaviors are more likely to experience recurrent cardiac events or death (2) . However, most patients with coronary heart disease do not follow a heart-healthy diet (3) , approximately 30% of post-ACS patients are nonadherent to medications even in the first 6 months after their event (4) , and in the weeks after an ACS, only one quarter of patients who are cleared to be active perform any type of exercise (5) .
Existing interventions do not seem to be sufficient to modify behavior. For example, fewer than half of 36 studied interventions for adherence to cardiovascular medications led to a significant improvement in medication adherence (6) . Likewise, motivational interviewing (MI), an established health behavior intervention, has had only modest effects (effect size approximately .2) on physical activity in patients at high risk for heart disease (7) . Regarding psychological interventions in heart disease, the vast majority have focused on reducing psychological ill-being, and most (8) (9) (10) , though not all (11) , have been applied only in patients with a clinical psychiatric condition (e.g., depression) rather than a broad population of cardiac patients. Furthermore, in cardiac patients, depression and anxiety treatments seem to improve mental health but have not consistently improved physical health outcomes or adherence (10, 12, 13) . Given the prevalence of nonadherence and importance of promoting cardiac health behaviors in this population, innovative and broadly applicable interventions to promote physical activity and other health behaviors are needed in post-ACS patients.
Psychological constructs may play an important role in health behavior adherence. For example, depression is linked to limited adherence to health behaviors and poor cardiovascular outcomes post-ACS (14) . In contrast, positive psychological constructs, such as positive affect and optimism, may have specific benefits (15) . These constructs are not simply the "flipside" of depression (with only modest inverse correlations between optimism and depression (16) , for example), and psychological well-being is associated with health behaviors, including physical activity, healthy diet, and medication adherence (15, 17) . Furthermore, positive affect and optimism are associated with lower incidence of heart disease (18) and mortality (19) , independent of sociodemographic variables, medical comorbidity, and the adverse effects of depression. Interventions promoting these positive constructs could therefore lead to greater adherence to key health behaviors and better cardiac health.
Positive psychology (PP) interventions focus on the cultivation of positive psychological constructs through systematic exercises, such as writing a letter of gratitude or using a strength in a new way (20) . In healthy persons, PP interventions have led to reductions in depression and increases in well-being (21) , and related programs in patients with hypertension or heart disease have led to greater physical activity and medication adherence (22, 23) . However, there has been no previous study of the impact of PP-based interventions in the high-risk, high-yield post-ACS period to assess whether they may improve well-being and promote health behaviors associated with greater survival.
To address this need, our team has applied the multiphase optimization strategy (MOST) (24) to develop a PP-based intervention to promote physical activity and other health behaviors after ACS. Based on the literature and extended interviews with post-ACS patients (25), we created an 8-week, telephone-based PP intervention and tested it in a small (N = 45) pilot trial. Compared with treatment-as-usual (TAU) patients, this intervention led to greater improvements in depression, anxiety, and positive affect (26) . The next phase, tested in this current trial, was to select the most effective components for inclusion in the intervention before testing it in a randomized efficacy trial.
To accomplish this, we conducted an eight-condition factorial trial in 128 patients hospitalized for an ACS to further assess the feasibility and overall impact of our intervention and to examine which components of the intervention were associated with the greatest improvements in moderate to vigorous physical activity (MVPA; primary outcome) and overall self-reported health behavior adherence. The specific aspects of the treatment that were compared included the frequency of PP exercise completion (weekly versus daily), the core content of the program (PP alone versus PP plus MI), and the presence or absence of booster sessions after the core program.
METHODS
Positive Emotions after Acute Coronary Events (PEACE) is a multiphase intervention development program using MOST to develop and optimize a PP-based intervention to promote physical activity in post-ACS patients. The current phase (PEACE-III), following qualitative and proof-of-concept phases (25, 26) , aimed to determine which elements of the intervention are most associated with improvements in physical activity, other health behaviors, psychological states, and other patient-centered outcomes. Detailed methods of this trial have previously been published (27) .
In short, this factorial design experiment was conducted to provide information about which components would be selected for inclusion in an optimized PP-based intervention that would subsequently be tested in a future randomized controlled efficacy trial. The factorial design allowed for the completion of three concurrent (n = 64 versus n = 64) comparisons of intervention components to facilitate efficient intervention development (28) . Components that showed consistent evidence for a main effect on health behavior outcomes in this trial would be included in the optimized intervention, even if the component or component level (e.g., weekly exercises) did not have a statistically significant main effect compared with the other component or level (e.g., daily exercises). Factorial trials have previously been used successfully in optimization of behavioral interventions to efficiently test multiple components via several concurrent comparisons (28) .
Before study initiation, the trial was registered on clinicaltrials.gov and approved by the Partners Healthcare Institutional Review Board. All participants provided full written informed consent.
Participants
Participants were adults admitted to an inpatient cardiology unit for an ACS at one of two urban academic medical centers between November 2014 and November 2016 who had suboptimal health behavior adherence (see CONSORT checklist document, Supplementary Table 1, Supplemental Digital Content 1, http://links.lww.com/PSYMED/A466). To meet criteria for myocardial infarction, consistent with international criteria (29) , participants were required to have two or more of the following: typical chest pain, elevated cardiac necrosis markers, and/or electrocardiographic changes consistent with myocardial infarction. Unstable angina, per previous studies (30) , required new-onset angina within 2 months, exacerbation of existing angina at rest or with minimal exercise, or angina within 2 weeks of a myocardial infarction. Health behavior adherence was measured using Medical Outcomes Study Specific Adherence Scale (MOS) (31) items for diet, medications, and physical activity (range = 4-24). Suboptimal adherence was defined as a summed MOS score of 14/18 or less, or a total score of 15 with a physical activity score of 5 or less. Patients were excluded if they demonstrated cognitive deficits on a six-item screen (32), had a medical condition likely to lead to death within 6 months, or were unable to communicate in English or participate in physical activity.
Procedures
Potential participants underwent screening for eligibility, and eligible patients completed written consent. In situations in which more than one patient could be approached, women and minority patients were approached preferentially given their historical underrepresentation in medical research and to meet funder-specified targets for women and minorities. During hospitalization, participants completed baseline outcome measures and then were randomized to one of the eight conditions (Table 1) using the Stata ralloc procedure in blocks of 16. Although all conditions were planned to contain 16 participants, an early allocation sequence error led to assignment of between 14 and 17 participants to each condition.
Study Interventions
After randomization, participants completed an in-person session with a study interventionist. At this session, the interventionist provided the participant with a treatment manual (see Supplementary Table 2 , Supplemental Digital Content 2, http://links.lww.com/PSYMED/A467, for sample pages). The interventionist also outlined the program, assigned the first PP exercise, and (for those with MI content) discussed physical activity and other health behavior goals. Of note, throughout the intervention (and this article), the term "PP exercise" refers to a PP-based activity (e.g., performing kind acts) rather than physical activity.
After discharge, participants completed eight weekly phone sessions during which the interventionist reviewed the previous week's exercise, helped participants translate skills to promote well-being in daily life, assigned a PP exercise for the next week, and (for those in MI conditions) outlined MI principles and assigned a health behavior goal. Half of participants completed three booster sessions with relevant PP and/or MI content at weeks 10, 12, and 14 after completion of the core 8-week program.
Positive Psychology
The PP exercises were chosen based on the literature and our previous work delivering PP interventions (25, 26) . Interventionists explained the rationale or each PP exercise type via guided review of the treatment manual; participants then completed exercise(s) independently during the week (on a daily or weekly basis, depending on group assignment) and wrote about the exercise and its effects. For example, participants in the weekly version of "Remembering Successes" recalled one past success and wrote in detail about it. Participants in the daily version wrote about smaller, daily successes. For those assigned to the MI component of the intervention related to goal setting for physical activity, the random assignment to daily or weekly PP exercise frequency had no bearing on the MI component of the intervention, with the discussion and nature of physical activity the same for all participants receiving MI.
The core eight weekly sessions involved completion of specific activities (e.g., writing a gratitude letter, using personal strengths in a new way; see Supplementary Table 3 , Supplemental Digital Content 3, http://links. lww.com/PSYMED/A468, for additional detail).
Motivational Interviewing
The MI intervention component focused primarily on physical activity, although participants could choose to complete another health behavior goal once they reached their activity goal. At each session, interventionists would (1) inquire about progress toward the previous week's goal, (2) advise participants about the benefits of physical activity (and other health behaviors as applicable), (3) assess participants' current stage of change, and (4) assist with setting a new goal. Each week, interventionists also introduced a new skill/tool related to behavior change (e.g., benefits of activity tracking, approaches to problem-solving barriers).
See Supplementary 
Booster Sessions
For participants randomized to booster sessions, PP boosters focused on the ongoing use of PP skills in daily life, with a goal of practicing one skill between sessions. For those also receiving MI, MI booster sessions reviewed ongoing physical activity goal progress, discussed relapse prevention, and revised long-term goals.
Sessions were audio-recorded, and intervention fidelity was rated by the study project director (CC) and behavioral intervention supervisor (EP) for PP and MI content, respectively. PP fidelity was rated using a scale created as part of intervention development (26) , and MI fidelity was rated with established MI fidelity scale and methods (33) .
Data Collection and Outcomes
Baseline sociodemographic, medical, and medication-related data were gathered via participant interview supplemented by chart review; enrollment in cardiac rehabilitation during the study period was likewise gathered via patient report and chart review. Self-report assessments were completed in-hospital (baseline) before randomization and by phone at 8 and 16 weeks by blinded study staff.
Study Aim #1: Feasibility, Acceptability, and Impact Across all Conditions
To examine intervention feasibility, we recorded frequency of completion of all assigned exercises. For acceptability, immediately after each PP exercise completion, participants rated the ease and helpfulness (utility) of that week's exercise on a 0 to 10 Likert scale. To examine the immediate impact of PP exercises, participants rated their positive affect and optimism (from 0 [not happy/optimistic] to 10 [very happy/optimistic]) immediately before and after completion of each exercise. The change in positive affect and optimism was considered to represent the immediate impact of the intervention on those constructs. Finally, we explored the overall pre-post impact of the PP-based intervention (summed across all conditions, given that every condition was an active intervention) on our self-report study outcome measures at 16 weeks.
Study Aim #2 (Primary Aim): Between-Condition Differences in MVPA at 16 Weeks MVPA, as measured by accelerometer, was chosen as the primary study outcome given its links to health outcomes, including mortality (34) . Participants wore Actigraph GT3X+ accelerometers (Actigraph, Pensacola, FL) at weeks 8 and 16, with the cutoff for MVPA set at 1952 counts/min. We did not record MVPA at baseline given that participants were hospitalized, but data on pre-ACS activity were collected using the 7-day Physical Activity Recall scale (35) to control for this in study analyses. Consistent with previous research (36) , participants were required to have 8 hours of wear time for at least 4 days; accelerometers were returned to participants for additional wear as needed.
Study Aim #3: Between-Condition Differences in Self-reported Adherence and Psychological Outcomes at 16 Weeks
The main secondary outcome measure was health behavior adherence, specifically adherence to physical activity, medication, and diet, measured using the MOS items capturing these three domains. Use of self-report items to measure cardiac health behaviors can be challenging, especially using very brief scales. The MOS Specific Adherence Scale has been used in numerous previous studies of post-ACS patients to examine cardiac health behaviors, (37-39) and this scale has been found to have test-retest reliability of .55 to (45) (46) (47) . Furthermore, self-report of dietary adherence using this scale in medical populations found that 23% to 60% met criteria for adherence (31, 48) , suggesting that respondents do not seem to grossly overestimate adherence to diet. We used this scale in several previous studies, including in post-ACS patients (38) , and found it to be responsive to change (M (SD) item change = 1.00 (1.3) for 6 months after ACS, representing 23% change), with no ceiling effects (mean item score = 4.3/6 for diet). Of note, for baseline assessments, participants were asked about pre-ACS adherence to these health behaviors.
We also examined the impact of the intervention on four key psychological constructs. Positive affect was measured via the positive affect subscale of the Positive and Negative Affect Schedule (PANAS; range = 10-50; internal consistency (α) in this sample = .87) (49) . Optimism was measured via the Life Orientation Test-Revised (LOT-R; range = 6-24); this scale has been previously used in studies of post-ACS patients (38, 50) and has been found to be significantly inversely correlated with depression and anxiety and to have good test-retest reliability and internal consistency (51, 52) 
Data Analysis
Baseline characteristics were summarized using descriptive statistics (means, proportions, and standard deviation [SD]); as per the CONSORT 2010 clinical trial reporting guidelines for randomized trials (54), group differences in baseline characteristics are reported but not compared with significance tests. Reporting the characteristics of groups allows readers to ascertain how similar groups are, but applying significance tests simply assesses the likelihood that such differences occurred by chance, when it is known that they would occur by chance given that participants were randomly allocated (55).
Aim #1: Feasibility, Acceptability, and Overall Impact
To assess feasibility, we calculated the mean number of sessions completed, first across all participants and then excluding immediate dropouts (those completing zero exercises). Next, we examined differences in frequency of exercise completion across treatment conditions for each of the three group comparisons (e.g., booster versus no booster) using a full factorial model (main effects and all two-and three-way interactions) using effect coding with values of -1/2 and 1/2 for each intervention. For acceptability, we calculated the means and SDs of the ease and utility scores. To examine the immediate impact of the intervention on optimism and positive affect, we assessed changes in pre-post 0 to 10 Likert scale ratings using generalized estimating equation models with an exchangeable working correlation structure. This analytic approach allowed us to account for intraindividual variability. A priori, we set 70% completion of assigned exercises, ratings of 7.0/10 on ease/utility scales, and significant (p < .05) pre-post improvements on happiness and optimism as benchmarks for feasibility, acceptability, and immediate impact. For the overall pre-post impact of the intervention (all conditions) at 16 weeks, we used the time coefficient from the random-effects regression model used for all self-report outcomes (see Aim #3) and calculated the pre-post effect size (ES; Cohen's d) on our outcome measures (self-reported adherence [MOS] , including the single exercise item, and psychological outcomes). For all aims, the ES was calculated by dividing the main effect coefficient of each variable at each time point by the SD of the residual in the regression model. We also observed the magnitude of the ES for each outcome as compared with those seen in participants randomized to the TAU condition in our previous trial in post-ACS patients (26) , allowing us to assess whether the intervention seemed to impact outcomes above and beyond the natural history of post-ACS recovery.
Aim #2: Between-Group Comparisons on MVPA
To compare the effect of the conditions on MVPA at 16 weeks, we used a random-effects model with main effects and interactions for each intervention and for time and intervention by time interactions, adjusting for pre-ACS physical activity via the 7-day Physical Activity Recall; we again used full factorial effect coding for the interventions. Comparisons (n = 64 versus n = 64) were made between boosters and no boosters, PP alone and PP-MI, and weekly versus daily PP exercise assignment. Secondary analyses repeated the analyses excluding immediate dropouts and adjusting for cardiac rehabilitation enrollment during the 16-week period.
With 128 patients, the study would have been powered at 80% to detect a medium ES (Cohen's d = .5) between-group difference in MVPA using α value of .05. Because all participants received an active PP-based intervention, we were aware that significant differences may not be observed. We therefore also focused on ES differences for each comparison, given that even nonsignificant between-group differences could inform decisions about selecting intervention components.
Aim #3: Comparison of Group Differences in Self-reported Adherence and Psychological Outcomes
Group differences on change in self-reported adherence (the MOS summed items and physical activity item) and psychological measures (PANAS, LOT-R, HADS-A, and HADS-D) at 16 weeks were assessed using an analysis of response profiles model with full factorial effect coding for the interventions, a categorical effect of time, a time by intervention interaction, and an unstructured covariance matrix, including the baseline value of each outcome. For this analysis, a common baseline was assumed because study participants were randomized to group; β values reported are scale dependent and not standardized values. As for Aim #2, along with tests for significance across the three between-group comparisons, we calculated ES differences. Given the potential for dietary adherence assessment to be less reliable, we repeated our analyses for health behavior adherence including only items for medication adherence and physical activity.
Analyses were performed using Stata 14.2 (College Station, TX); all tests were two-tailed and α value was set at .05; if a Bonferroni correction was used given the three concurrent comparisons, α value would be .0167.
RESULTS

Baseline Data
A total of 128 hospitalized patients were enrolled (see CONSORT diagram, Fig. 1 ). Of these, 26 (20%) were immediate dropouts (zero exercises completed); follow-up data were obtained from 97 participants (76% of total participants and 87% [89/102] of those who were not immediate dropouts). Baseline sociodemographic, medical, and psychological characteristics are provided in Table 2 . At baseline, 48 (38.1%) and 31 (24.6%) participants scored above the HADS-A and HADS-D cutoffs [>7] for possible clinically significant anxiety and depression, respectively. Participants were somewhat younger than ACS patients who were approached but did not enroll (66.3 years [SD = 11.9]), and the cohort also had greater representation of women and minority participants (nonenrolling approached patients: 39% women, 21% minority).
Feasibility
Participants completed a M (SD) of 5.14 (3.33) of the eight potential initial weekly sessions (64% of all possible sessions); excluding immediate dropouts, participants (n = 102) completed a M (SD) of 6.45 (2.32) sessions (81% of all possible sessions). There were no significant between-group differences in the number of exercises completed across any of the three comparisons (boosters versus nonboosters, PP-MI versus PP-only, weekly versus daily).
Acceptability and Immediate Impact
Participants' M (SD) ratings (0-10 Likert scale) of PP exercise ease and utility were 7.88 (2.2) and 7.92 (2.2), respectively. There were significant improvements in positive affect (M (SD) pre-exercise happiness = 7.35 (2.0), mean postexercise improvement = 0.86, t = 9.35, p < .001) and optimism (M (SD) pre-exercise optimism = 7.73 (1.9), mean improvement = 0.44, t = 6.33, p < .001) immediately after exercise completion.
For overall impact across all conditions, the PP-based intervention was associated with pre-post improvements in overall adherence (M (SD) baseline score = 11. 
Moderate to Vigorous Physical Activity
For the main study aims related to the three concurrent group comparisons on MVPA (primary study outcome measure) and other outcomes at 16 weeks (Table 3) 
Health Behavior Adherence
Regarding the main secondary aim examining group differences in MOS score at 16 weeks (Table 3) , there was a significant effect of MI content on MOS improvement (p = .044, ES = .39), and nonsignificant effects in favor of weekly exercises (p = .48, ES = .14) and booster sessions (p = .20, ES = .25). Secondary analyses were similar, with the MI condition effect on adherence remaining significant when adjusting for cardiac rehabilitation enrollment and excluding immediate dropouts. When excluding diet, we found the effects of MI and booster sessions to have continued but attenuated and nonsignificant associations with self-reported adherence (see Supplementary Table 4 , Supplemental Digital Content 4, Female sex 76 (59) 13 (81) 9 (56) 8 (50) 12 (71) 6 (40) 10 (59) 8 (47) 10 (71) White race 94 (73) 11 (69) 12 (75) 12 (75) 14 (82) 8 (53) 12 (71) 14 (82) 11 (79) Married 70 (55) 7 (44) 8 (50) 10 (63) 10 (59) 7 (47) 8 (47) 10 (59) 10 (71) Lives alone 36 (29) 4 (27) 5 (31) 3 (19) 6 (35) 5 (33) 4 (25) 4 (24) 5 (36) Medical characteristics Admission diagnosis of MI 75 (59) 10 (63) 12 (75) 10 (63) 10 (59) 7 (47) 8 (47) 10 (59) 8 ( (27) 3 (19) 1 (6) 5 (31) 9 (53) 4 (27) 2 (12) 5 (29) 6 (43) Current smoker
18 (14) 1 (6) 2 (13) 1 (6) 3 (18) 2 (13) 3 (18) 4 (24) 2 (14) Hypertension 112 (88) 13 (81) 12 (75) 15 (94) 16 (94) 15 (100) 16 (94) 13 (76) 12 (86) Hyperlipidemia 103 (80) 13 (81) 13 (81) 12 (75) 12 (71) 15 (100) 11 (65) 15 (88) 12 (86) Previous ACS 42 (33) 5 (31) 8 (50) 4 (25) 4 (24) 8 (53) 3 (18) 5 (29) 5 ( (12) 57 (11) 57 (14) 57 (13) 58 (18) 59 (11) 55 (9) 56 (10) 60 (9) Antidepressant treatment at discharge 27 (21) 3 (19) 3 (19) 4 (25) 5 (29) 3 (20) 1 (6) 5 (29) 3 (21) Anxiolytic treatment at discharge
19 (15) 4 (25) 1 (6) 2 (13) 1 (6) 0 (0) 3 (18) 3 (18) 5 ( For all study outcomes, we also examined all two-way and three-way interactions, and only one was significant: the combination of daily exercises without booster sessions led to fewer depressive symptoms at 16 weeks. Finally, there were no differences in serious adverse events by group. Pre and posttreatment means and SD of outcome data are displayed for all eight conditions in Supplementary 
DISCUSSION
In sum, a phone-delivered, PP-based intervention was well accepted in this cohort of recently hospitalized ACS patients. The intervention-across all conditions-was also associated with improvement in health behavior adherence and psychological outcomes in post-ACS patients. Furthermore, we found somewhat consistent between-condition differences on our main health behavior outcome measures, generally in favor of booster sessions, combined PP and MI content, and weekly PP exercise assignment.
Participants' reports of exercise ease, exercise utility, and prepost improvements in well-being all reached or surpassed the trial's a priori benchmarks for acceptability. The intervention's feasibility was more mixed, with 20% of participants dropping out before completing any exercises. Immediately after hospitalization, some participants had ongoing cardiac issues complicating participation, and some had underestimated posthospitalization time demands. Our cohort may have been at elevated risk for dropout. Participants had suboptimal physical activity at baseline and were recruited in-hospital (with a corresponding risk of rapid readmission), and previous work has found that unplanned admissions (56) and low baseline physical activity among behavioral intervention study participants (57) have both been associated with elevated risk of early dropout. These factors suggest that despite being a "teachable moment," hospitalization may not be the ideal time for intervention initiation, and waiting 1 to 2 weeks may allow more appropriate selection and participation. Of note, excluding immediate dropouts, participants completed more than 80% of all possible sessions, and 87% provided follow-up data, suggesting that once post-ACS participants engaged, the phone-delivered intervention was quite feasible.
The PP-based intervention, across all conditions, led to immediate improvement in positive affect and happiness, as well as sustained improvement in psychological well-being for 16 weeks. These findings are consistent with studies of PP-based interventions in other populations that found short-term (58) and sustained (20, 59) improvements in psychological health. The intervention was also associated with improvement in self-reported health behaviors; previous PP interventions have had more mixed effects on this outcome (22, 23, 60) . The intervention also had a greater overall impact on psychological and behavioral outcomes at 8 weeks when compared with post-ACS patients receiving TAU for the same period in our previous work (26) .
Regarding our primary study goals, we generally found that continuation of the intervention beyond 8 weeks (via booster sessions) was associated with greater physical activity. Although it may seem unsurprising that adding booster sessions may lead to greater improvement, the behavioral intervention literature has been somewhat mixed on the use of booster sessions (61, 62) , necessitating a specific evaluation in this trial. We also found that adding an MI component to the intervention was associated with generally-though not universally-better outcomes. Although the effects of MI were surprisingly equivocal on MVPA, MI was superior for overall self-reported health behavior adherence. Although the MI intervention could have increased participant cognitive burden despite time matching of the PP and PP-MI interventions, frequency of intervention completion was not lower with MI.
This combination of PP and MI may be appealing, because MI alone has been associated with only small-moderate effects on physical activity in cardiac and related conditions (63) . Furthermore, specific subgroups may be less likely to benefit from MI alone, such as those with low expectation of improvement or low overall optimism (64, 65) and a PP component could boost well-being and motivation to better prepare patients to make change via MI. An important next step would be to compare a PP-MI intervention to MI alone. Finally, weekly PP exercise assignment seemed to be modestly more effective than daily exercise assignment, including psychological measures. This is consistent with previous studies in nonmedical populations finding that completing PP activities in a more clustered, intermittent manner is linked to greater improvement in well-being (66) . Given that weekly exercise completion is less burdensome for patients and was associated with generally equal or better impact on outcomes, weekly PP exercise assignment may be optimal for this intervention.
Overall, this dose-finding trial worked well within our multiphase optimization strategy. The goal of this factorial design trial was to efficiently and concurrently answer several questions about intervention content, duration, and intensity of this program within 128 post-ACS patients, and three separate trials of 128 patients would not have provided additional information. Factorial design experiments within a MOST framework have been used successfully to optimize behavioral interventions (24,28), and we were likewise able to reach consensus on the optimal components of this program.
The strengths of this study included a reasonably diverse sample of nearly 30% minority participants and a nearly equal split between men and women, as well as inclusion of both objective and self-report measures of adherence. The trial also had several limitations, including the relatively high frequency of initial dropout, leading to lower power than originally planned, although followup data were available from the vast majority of the remaining population. The use of brief self-report to measure adherence, especially diet, using the MOS is an additional limitation given the brief nature of this scale, difficulty measuring diet in this manner, and relatively limited data on reliability and validity. In addition, this was not a formal efficacy trial, and although the pre-post improvements in adherence that were larger than seen in a previous post-ACS cohort receiving TAU suggest that the intervention may have promise, such data are by no means definitive and a specific trial of the optimized intervention, compared with a relevant control condition, is required as a next step.
In conclusion, this factorial design trial allowed us to gather information about numerous aspects of intervention content and delivery. A next-step PP-based intervention in post-ACS patients would likely include MI, weekly PP exercises, and booster/ continuation sessions to reinforce intervention and may best be initiated several weeks after hospitalization. Ultimately, if this phone-delivered PP-based intervention can improve physical activity in post-ACS patients, this could substantially improve prognosis and have a substantial public health benefit.
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